Europe Genomics Market to 2025 - Regional Analysis and Forecasts by Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction and Purification and Others), Product & Service (Instruments/Systems, Consumables and Services), Application (Diagnostics, Drug Discovery and Development, Precision/Personalized Medicine, Agriculture & Animal Research and Others) End User (Research Centers, Hospitals and Clinics, Pharmaceutical & Biotechnology Companies and Others) and Country
Publication Month: Apr 2019
Report Code: TIPRE00004302 No. of Pages: 188 Category: Biotechnology Status: Published
The Europe genomics market is expected to reach US$ 10.1 Bn in 2025 from US$ 4.6 Bn in 2017. The market is estimated to grow with a CAGR of 10.6% from 2018-2025.
The growth of the market is driven by the factors such as, rise in the advancements for genome editing technologies and technological developments in genomics. However, the market is likely to get impacted due to nonexistence of skilled professionals and risks associated with genetic data in genomics in the region.
The biotechnological field is characterized as a continuously developing the technologies for the betterment of the health for all the living organisms. Therefore, the technologies for the genome editing is undergoing various advancements, the most recent advancement for the genome editing is utilizing the nucleases which include the zinc finger nuclease (ZFN), transcription activators like effector nuclease (TALEN) and (clustered regulatory interspaced short palindromic repeats) CRISPR Cas9 system. The technologies has been successfully implemented in the several crops, including the Solanaceae plants, such as tomato, potato, tobacco and petunia. CRISPR Case 9 among the three nucleases is the best for breeding, crop improvement and the functional analysis of genes of interest. The technology is best due to its simplicity and high efficiency.
The technological advancements are being carried out by most of the biotechnological companies. The companies are continuously involved in the research and development for the technologies and producing the products for the genome editing. In addition, most of the start-up companies are involved in the development of the genome editing tools and services. For instance, UK based company, Horizon Discovery have discovered cell lines, the company has utilized the ability of the rAAV’s to amplify the cell's own high fidelity DNA repair pathway. Moreover, the company is also license out its nuclease-based genome editing technologies to improve our efficiencies still further at first Zinc Finger Nucleases (ZFNs) and then CRISPR Cas9 gene editing. Thus, the technological advancement for genome editing tools by the market players and the start-up companies are likely to drive the market for the genome editing market in the forecast period.
Germany is expected to lead the market in the Europe region due to presence of large biotech players, high-tech research labs and massive funding for conduction of research and development. Moreover, the cutting edge and high-quality research present in the country creates lucrative opportunity and presence of an established market for gene synthesis. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Europe region during the forecast period.
EUROPE GENOMICS – MARKET SEGMENTATION
By Technology
The growth of the market is driven by the factors such as, rise in the advancements for genome editing technologies and technological developments in genomics. However, the market is likely to get impacted due to nonexistence of skilled professionals and risks associated with genetic data in genomics in the region.
The biotechnological field is characterized as a continuously developing the technologies for the betterment of the health for all the living organisms. Therefore, the technologies for the genome editing is undergoing various advancements, the most recent advancement for the genome editing is utilizing the nucleases which include the zinc finger nuclease (ZFN), transcription activators like effector nuclease (TALEN) and (clustered regulatory interspaced short palindromic repeats) CRISPR Cas9 system. The technologies has been successfully implemented in the several crops, including the Solanaceae plants, such as tomato, potato, tobacco and petunia. CRISPR Case 9 among the three nucleases is the best for breeding, crop improvement and the functional analysis of genes of interest. The technology is best due to its simplicity and high efficiency.
The technological advancements are being carried out by most of the biotechnological companies. The companies are continuously involved in the research and development for the technologies and producing the products for the genome editing. In addition, most of the start-up companies are involved in the development of the genome editing tools and services. For instance, UK based company, Horizon Discovery have discovered cell lines, the company has utilized the ability of the rAAV’s to amplify the cell's own high fidelity DNA repair pathway. Moreover, the company is also license out its nuclease-based genome editing technologies to improve our efficiencies still further at first Zinc Finger Nucleases (ZFNs) and then CRISPR Cas9 gene editing. Thus, the technological advancement for genome editing tools by the market players and the start-up companies are likely to drive the market for the genome editing market in the forecast period.
Germany is expected to lead the market in the Europe region due to presence of large biotech players, high-tech research labs and massive funding for conduction of research and development. Moreover, the cutting edge and high-quality research present in the country creates lucrative opportunity and presence of an established market for gene synthesis. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Europe region during the forecast period.
Exhibit: Rest of Europe Genomics Market Revenue and Forecasts to 2025 (US$ Mn)
EUROPE GENOMICS – MARKET SEGMENTATION
By Technology
- Sequencing
- Microarray
- Polymerase Chain Reaction
- Nucleic Acid Extraction and Purification
- Others
- Instruments/Systems
- Consumables
- Services
- Diagnostics
- Drug Discovery and Development
- Precision/Personalized Medicine
- Agriculture & Animal Research
- Others
- Research Centers
- Hospitals & Clinics
- Biotechnology & Pharmaceutical Companies
- Others
- Europe
- Germany
- UK
- France
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Eurofins
- Qiagen
- Agilent Technologies
- BGI
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche AG,
- Danaher
- GE Healthcare
PART 1. iNTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
PART 2. Europe GENOMICS Market – Key takeaways
PART 3. Europe genomics market – market landscape
3.1 overview
3.2 market segmentation
3.2.1 Europe Genomics Market – By Technology
3.2.2 Europe Genomics Market – By Product & Services
3.2.3 Europe Genomics Market – By Application
3.2.4 Europe Genomics Market – By End User
3.2.5 Europe Genomics Market – By Country
3.3 PEST Analysis
PART 4. Europe genomics market-Key Market Dynamics
4.1 Key Market Drivers
4.1.1 Rise in the Advancements For Genome Editing Technologies
4.1.2 Technological Developments in Genomics
4.2 Key Market Restraints
4.2.1 Nonexistence of Skilled Professionals
4.2.2 Risks Associated With Genetic Data
4.3 Key Market Opportunities
4.3.1 Extensive Use of Genomics for Medical Applications
4.4 future Trends
4.4.1 Usage of Gene Synthesis in Personalized Medicine
4.5 Impact analysis
PART 5. Genomics market – Europe Analysis
5.1 Europe GENOMICS market Revenue Forecasts and Analysis
5.2 Market positioning/ market share
5.3 PERFORMANCE OF KEY PLAYERS
5.3.1 Thermo Fisher Scientific Inc.
5.3.2 Illumina, Inc.
5.4 expert opinions
PART 6. Europe GENOMICS market Analysis – By Technology
6.1 Overview
6.2 Europe GENOMICS MARKET, BY technology, 2017 & 2025 (%)
6.3 Europe GENOMICS market Revenue And Forecasts to 2025, By Technology (US$ Mn)
6.4 sequencing market
6.4.1 Overview
6.4.2 Europe Sequencing Market Revenue and Forecasts to 2025 (US$ Mn)
6.5 microarray market
6.5.1 Overview
6.5.2 Europe Microarray Market Revenue and Forecasts to 2025 (US$ Mn)
6.6 Polymerase chain reaction (PCR) Market
6.6.1 Overview
6.6.2 Europe Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2025 (US$ Mn)
6.7 Nucleic Acid Extraction and Purification market
6.7.1 Overview
6.7.2 Europe Nucleic Acid Extraction and Purification Market Revenue and Forecasts to 2025 (US$ Mn)
6.8 Others market
6.8.1 Overview
6.8.2 Europe Others Market Revenue and Forecasts to 2025 (US$ Mn)
PART 7. Europe genomics market Analysis – By product & Service
7.1 Overview
7.2 Europe GENOMICS MARKET, BY product & service, 2017 & 2025 (%)
7.3 Europe GENOMICS market Revenue And Forecasts to 2025, By product & service (US$ Mn)
7.4 Instruments/Systems market
7.4.1 Overview
7.4.2 Europe Instruments/Systems Market Revenue and Forecasts to 2025 (US$ Mn)
7.5 consumables market
7.5.1 Overview
7.5.2 Europe Consumables Market Revenue and Forecasts to 2025 (US$ Mn)
7.6 Services Market
7.6.1 Overview
7.6.2 Europe Services Market Revenue and Forecasts to 2025 (US$ Mn)
PART 8. Europe genomics market Analysis – By Application
8.1 Overview
8.2 Europe GENOMICS MARKET, BY Application, 2017 & 2025 (%)
8.3 Europe GENOMICS market Revenue And Forecasts to 2025, By Application (US$ Mn)
8.4 diagnostics Market
8.4.1 Overview
8.4.2 Europe Diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)
8.5 Drug Discovery & Development Market
8.5.1 Overview
8.5.2 Europe Drug Discovery & Development Market Revenue and Forecasts to 2025 (US$ Mn)
8.6 Precision/Personalized Medicine Market
8.6.1 Overview
8.6.2 Europe Precision/Personalized Medicine Market Revenue and Forecasts to 2025 (US$ Mn)
8.7 Agriculture & Animal Research Market
8.7.1 Overview
8.7.2 Europe Agriculture & Animal Research Market Revenue and Forecasts to 2025 (US$ Mn)
8.8 Others Market
8.8.1 Overview
8.8.2 Europe Others Market Revenue and Forecasts to 2025 (US$ Mn)
PART 9. Europe genomics market Analysis – By End User
9.1 Overview
9.2 Europe GENOMICS MARKET, BY end user, 2017 & 2025 (%)
9.3 Europe GENOMICS market Revenue And Forecasts to 2025, By end user (US$ Mn)
9.4 Research centers Market
9.4.1 Overview
9.4.2 Europe Research Centers Market Revenue and Forecasts to 2025 (US$ Mn)
9.5 Hospitals & Clinics Market
9.5.1 Overview
9.5.2 Europe Hospitals & Clinics Market Revenue and Forecasts to 2025 (US$ Mn)
9.6 Pharmaceutical & Biotechnology Companies Market
9.6.1 Overview
9.6.2 Europe Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2025 (US$ Mn)
9.7 Others Market
9.7.1 Overview
9.7.2 Europe Others Market Revenue and Forecasts to 2025 (US$ Mn)
PART 10. Europe genomics market Revenue and Forecasts to 2025
10.1 Overview
10.2 Europe Genomics market Revenue and Forecasts to 2025 (US$ Mn)
10.3 Europe Genomics market Revenue And Forecasts to 2025, By Technology (US$ Mn)
10.4 Europe Genomics market Revenue And Forecasts to 2025, By Product & Service (US$ Mn)
10.5 Europe Genomics market Revenue And Forecasts to 2025, By Application (US$ Mn)
10.6 Europe Genomics market Revenue And Forecasts to 2025, By End User (US$ Mn)
10.7 Europe Genomics market Revenue And Forecasts to 2025, By Country (%)
10.8 Germany Genomics market Revenue and Forecasts to 2025 (US$ Mn)
10.8.1 Germany Genomics Market Revenue and Forecasts to 2025 (US$ Mn)
10.8.2 Germany Genomics Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
10.8.3 Germany Genomics Market Revenue And Forecasts to 2025, By Product & Service (US$ Mn)
10.8.4 Germany Genomics Market Revenue And Forecasts to 2025, By Application (US$ Mn)
10.8.5 Germany Genomics Market Revenue And Forecasts to 2025, By End User (US$ Mn)
10.9 UK Genomics market Revenue and Forecasts to 2025 (US$ Mn)
10.9.1 UK Genomics market Revenue and Forecasts to 2025 (US$ Mn)
10.9.2 UK Genomics Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
10.9.3 UK Genomics Market Revenue And Forecasts to 2025, By Product & Service (US$ Mn)
10.9.4 UK Genomics Market Revenue And Forecasts to 2025, By Application (US$ Mn)
10.9.5 UK Genomics Market Revenue And Forecasts to 2025, By End User (US$ Mn)
10.10 France Genomics market Revenue and Forecasts to 2025 (US$ Mn)
10.10.1 France Genomics Market Revenue and Forecasts to 2025 (US$ Mn)
10.10.2 France Genomics Market Revenue And Forecasts to 2025, By Technology (US$ Mn)
10.10.3 France Genomics Market Revenue And Forecasts to 2025, By Product & Service (US$ Mn)
10.10.4 France Genomics Market Revenue And Forecasts to 2025, By Application (US$ Mn)
10.10.5 France Genomics Market Revenue And Forecasts to 2025, By End User (US$ Mn)
PART 11. genomics Market –Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Genomics Market, 2015-2018
11.3 Organic Growth Strategies
11.3.1 Overview
11.3.2 Product Launch
11.3.3 Approvals
11.3.4 Expansion
11.3.5 Product Expansion
11.3.6 Others
11.4 Inorganic Growth Strategies
11.4.1 Overview
11.4.2 Partnership
11.4.3 Acquisition
11.4.4 Collaboration
11.4.5 Agreement
PART 12. genomics market –Key company profiles
12.1 Beijing Genomics Institute
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Financial Overview
12.1.4 Product & Services Portfolio
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Financial Overview
12.2.4 Product Portfolio
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Danaher
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Financial Overview
12.3.4 Product Portfolio
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bio-Rad Laboratories, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Financial Overview
12.4.4 Product Portfolio
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 General Electric
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Financial Overview
12.5.4 Product Portfolio
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 tHERMOfISHER SCIENTIFIC Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Financial Overview
12.6.4 Product Portfolio
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Agilent technologies
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Financial Overview
12.7.4 Product Portfolio
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 illumina, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 Product Portfolio
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Eurofins Scientific
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Financial Overview
12.9.4 Product/ Services Portfolio
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 QIAGEN
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 Product Portfolio
12.10.5 Swot Analysis
12.10.6 Key Developments
PART 13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
13.3 Methodology
13.3.1 Coverage
13.3.2 Secondary Research
13.3.3 Primary Research
list of tables
TABLE 1. Europe GENOMICS market Revenue And Forecasts to 2025, By Technology (US$ Mn)
TABLE 2. Europe GENOMICS market Revenue And Forecasts to 2025, By product & service (US$ Mn)
TABLE 3. Europe GENOMICS market Revenue And Forecasts to 2025, By Application (US$ Mn)
TABLE 4. Europe GENOMICS market Revenue And Forecasts to 2025, By end user (US$ Mn)
TABLE 5. Europe Genomics market Revenue And Forecasts to 2025, By Technology (US$ Mn)
TABLE 6. Europe Genomics market Revenue And Forecasts to 2025, By Product & Service (US$ Mn)
TABLE 7. Europe Genomics market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 8. Europe Genomics market Revenue And Forecasts to 2025, By end user (US$ Mn)
TABLE 9. Germany Genomics market Revenue And Forecasts to 2025, By Technology (US$ Mn)
TABLE 10. Germany Genomics market Revenue And Forecasts to 2025, By Product & Service (US$ Mn)
TABLE 11. Germany Genomics market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 12. Germany Genomics market Revenue And Forecasts to 2025, By end user (US$ Mn)
TABLE 13. UK Genomics market Revenue And Forecasts to 2025, By Technology (US$ Mn)
TABLE 14. UK Genomics market Revenue And Forecasts to 2025, By Product & Service (US$ Mn)
TABLE 15. UK Genomics market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 16. UK Genomics market Revenue And Forecasts to 2025, By end user (US$ Mn)
TABLE 17. France Genomics market Revenue And Forecasts to 2025, By Technology (US$ Mn)
TABLE 18. France Genomics market Revenue And Forecasts to 2025, By Product & Service (US$ Mn)
TABLE 19. France Genomics market Revenue And Forecasts to 2025, By application (US$ Mn)
TABLE 20. France Genomics market Revenue And Forecasts to 2025, By end user (US$ Mn)
TABLE 21. Recent Product Launch in the Genomics Market
TABLE 22. Product Enhancement & Software Upgradation in the Genomics Market
TABLE 23. Expansion Organic Growth Strategies in the Genomics Market
TABLE 24. Product Expansion Organic Growth Strategies in the Genomics Market
TABLE 25. Others Organic Growth Strategies in the Genomics Market
TABLE 26. Recent Partnership in the Genomics market
TABLE 27. Recent Acquisition in the Genomics market
TABLE 28. Recent Collaboration in the Genomics market
TABLE 29. Recent Agreement in the Genomics market
TABLE 30. Glossary of Terms, GENOMICS market
list of figures
FIGURE 1. Germany genomics market, Revenue (US$ Mn), By COuntry 2018 & 2025
FIGURE 2. EUrope Genomics Market By technology, Market Share (%), 2017
FIGURE 3. EUrope Genomics Market By product & service, Market Share (%), 2017
FIGURE 4. EUrope Genomics Market By application, Market Share (%), 2017
FIGURE 5. EUrope Genomics Market By end user, Market Share (%), 2017
FIGURE 6. genomics market Segmentation
FIGURE 7. Europe PEST Analysis
FIGURE 8. genomics market impact analysis of drivers & Restraints
FIGURE 9. Europe GENOMICS market – Revenue Forecasts and Analysis – 2017- 2025
FIGURE 10. Europe genomics Market – key market players
FIGURE 11. Europe GENOMICS market, By technology, 2017 & 2025 (%)
FIGURE 12. Europe sequencing Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 13. Europe microarray Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 14. Europe polymerase chain reaction (PCR) Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 15. Europe Nucleic Acid Extraction and Purification Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 16. Europe Others Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 17. Europe GENOMICS market By product & service, 2017 & 2025 (%)
FIGURE 18. Europe instruments/systems market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 19. Europe consumables market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 20. Europe services market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 21. Europe GENOMICS market By Application, 2017 & 2025 (%)
FIGURE 22. Europe diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 23. Europe drug discovery & development Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 24. Europe precision/personalized medicine Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 25. Europe agriculture & animal research Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 26. Europe others Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 27. Europe GENOMICS market By end user, 2017 & 2025 (%)
FIGURE 28. Europe Research centers Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 29. Europe hospitals & Clinics Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 30. Europe pharmaceutical & biotechnology companies Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 31. Europe Others Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 32. Europe genomics market REVENUE overview, by Country, 2017 (US$ MN)
FIGURE 33. Europe Market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 34. Europe Genomics market Revenue And Forecasts to 2025, By Country (%)
FIGURE 35. Germany Genomics market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 36. UK genomics market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 37. France Genomics market Revenue and Forecasts to 2025 (US$ Mn)
FIGURE 38. Growth Strategies in the Genomics Devices Market, 2015-2018
FIGURE 39. Organic Growth Strategies in the Genomics Market, 2015-2018
FIGURE 40. Inorganic Growth Strategies in the Genomics Market, 2015-2018
The List of Companies
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Eurofins
- Qiagen
- Agilent Technologies
- BGI
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche AG,
- Danaher
- GE Healthcare